Exciting News! The Anti-Tumor New Drug IND from Hexin Biopharmaceutical ...

Author: Xiaoxin He | Date: 2025-03-10

        Recently, Hexin Biopharmaceutical (Changchun) Co., Ltd. received thrilling news: its independently developed anti-tumor drug XY003 has...

Chinese scientists have discovered that quadruplexed DNA can be used as ...

Author: DeepTech | Date: 2024-11-01

Returning to China to start a business is Xu Hong's next destination."Now that I've left Canada, I'm back home to form a company to develop quadruplex DNA...

Honor Wall of Horizon Omics Biotechnology (Changchun) Co., Ltd.

Author: Xiaoxin He | Date: 2024-11-01

Latest Published Articles by Horizon Omics Biotechnology (Changchun) Co....

Author: Xiaoxin He | Date: 2024-11-01

        Horizon Omics Biotechnology (Changchun) Co., Ltd. published the article titled "A Synthetic Lethal Approach to Drug Targeting of G-Quadruplexes...

Horizon Omics Biotechnology 2022 Published Article

Author: Xiaoxin He | Date: 2024-11-01

        Horizon Omics Biotechnology (Changchun) Co., Ltd. published the article "A First-in-Class Clinical G-Quadruplex-Targeting Drug: The Bench-to...

A Showcase of Award-Winning Enterprises from Previous Innovation and...

Author: People's Daily Online - Jilin Channel | Date: 2024-11-01

In May 2022, registration for the 11th China Innovation and Entrepreneurship Competition (Jilin Region) began. This marked the seventh time that the...